CHANGE.A Randomized Clinical Trial of Health Promoting Programme Versus Standard Treatment for Patients With Schizophrenia
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
The primary outcome is HbA1C change from baseline at 12 months. The HbA1C which is a proxy for glucose level withing the last 8 to 12 weeks.
Merete Nordentoft, Professor
Mental Health Centre Copenhagen
Denmark: National Board of Health